Fierce Pharma Feature: Small molecule biomarkers in precision medicine
Por um escritor misterioso
Descrição
This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.
Is precision medicine really the best approach to improving health? - STAT
Small molecules, big impact: 20 years of targeted therapy in oncology - The Lancet
Integration of personalized drug delivery systems into digital health - ScienceDirect
Metabolomics: small molecules that matter more - Molecular Omics (RSC Publishing) DOI:10.1039/D0MO00176G
It's in Our Blood: A Glimpse of Personalized Medicine: Trends in Molecular Medicine
The role of precision nutrition in the modulation of microbial composition and function in people with inflammatory bowel disease - The Lancet Gastroenterology & Hepatology
Frontiers Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
Cancers, Free Full-Text
Bioanalysis of small and large molecule drugs, metabolites, and biomarkers by LC-MS - ScienceDirect
Biomarker development in the precision medicine era: lung cancer as a case study
CPHI: In Pharma Services, Where Have All the Entrepreneurs Gone? (webinar)
2021's Fiercest Women in Life Sciences
CPHI: ESG Risks in Pharma and Biotech – How to Manage your Exposure (webinar)
de
por adulto (o preço varia de acordo com o tamanho do grupo)
